TG Therapeutics is eyeing the first quarter of 2023 for Briumvi’s commercial launch, the company said in a release, without disclosing pricing plans. (TG Therapeutics) Half a year after the FDA ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results